Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | +1.94% | -40.68% | -54.35% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Willard
CEO | Chief Executive Officer | 63 | 22-07-11 |
Jonathan Javitt
FOU | Founder | 67 | 17-09-17 |
Richard Narido
DFI | Director of Finance/CFO | 46 | 23-09-12 |
Chief Tech/Sci/R&D Officer | - | 22-12-04 | |
Rick Panicucci
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Corporate Officer/Principal | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Javitt
FOU | Founder | 67 | 17-09-17 |
Stephen Willard
CEO | Chief Executive Officer | 63 | 22-07-11 |
Janet Rehnquist
BRD | Director/Board Member | - | 12-26 |
Patrick J. Flynn
BRD | Director/Board Member | 75 | 21-05-23 |
Chaim Hurvitz
BRD | Director/Board Member | 63 | 21-05-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,555,405 | 7,680,213 ( 72.76 %) | 0 | 72.76 % |
Stock B | 0 | 3,000,000 | 0 | 0 |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.35% | 21.88M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- BRPA Stock
- Company NRx Pharmaceuticals, Inc.